Cargando…

Metastatic Melanoma: Liquid Biopsy as a New Precision Medicine Approach

Precision medicine has driven a major change in the treatment of many forms of cancer. The discovery that each patient is different and each tumor mass has its own characteristics has shifted the focus of basic and clinical research to the singular individual. Liquid biopsy (LB), in this sense, pres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ricciardi, Elena, Giordani, Elena, Ziccheddu, Giovanna, Falcone, Italia, Giacomini, Patrizio, Fanciulli, Maurizio, Russillo, Michelangelo, Cerro, Marianna, Ciliberto, Gennaro, Morrone, Aldo, Guerrisi, Antonino, Valenti, Fabio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962821/ https://www.ncbi.nlm.nih.gov/pubmed/36835424 http://dx.doi.org/10.3390/ijms24044014

Ejemplares similares

Precision Medicine and Melanoma: Multi-Omics Approaches to Monitoring the Immunotherapy Response
por: Valenti, Fabio, et al.
Publicado: (2021)

Artificial Intelligence and Advanced Melanoma: Treatment Management Implications
por: Guerrisi, Antonino, et al.
Publicado: (2022)

Exploring CT Texture Parameters as Predictive and Response Imaging Biomarkers of Survival in Patients With Metastatic Melanoma Treated With PD-1 Inhibitor Nivolumab: A Pilot Study Using a Delta-Radiomics Approach
por: Guerrisi, Antonino, et al.
Publicado: (2021)

Unusual phylogenetic tree and circulating actionable ESR1 mutations in an aggressive luminal/HER2-low breast cancer: Case report
por: Allegretti, Matteo, et al.
Publicado: (2023)

Liquid biopsy identifies actionable dynamic predictors of resistance to Trastuzumab Emtansine (T-DM1) in advanced HER2-positive breast cancer
por: Allegretti, Matteo, et al.
Publicado: (2021)

The Molecular Tumor Board of the Regina Elena National Cancer Institute: from accrual to treatment in real-world
por: Giacomini, Patrizio, et al.
Publicado: (2023)

Novel cancer therapies for advanced cutaneous melanoma: The added value of radiomics in the decision making process–A systematic review
por: Guerrisi, Antonino, et al.
Publicado: (2020)

Factors to Consider for the Correct Use of γH2AX in the Evaluation of DNA Double-Strand Breaks Damage Caused by Ionizing Radiation
por: Valente, Davide, et al.
Publicado: (2022)

Tearing down the walls: FDA approves next generation sequencing (NGS) assays for actionable cancer genomic aberrations
por: Allegretti, Matteo, et al.
Publicado: (2018)

The role of ultrasound and ultrasound-guided fine needle aspiration biopsy of lymph nodes in patients with skin tumours
por: Solivetti, Francesco Maria, et al.
Publicado: (2014)

Precision diagnostics of Ewing’s sarcoma by liquid biopsy: circulating EWS-FLI1 fusion transcripts
por: Allegretti, Matteo, et al.
Publicado: (2018)

Reorganization of Istituti Fisioterapici Ospitalieri, an oncological and dermatological clinical and research center, to face the coronavirus health emergency: adopted measures and metrics of success to achieve and keep a COVID-19-free status
por: De Luca, Assunta, et al.
Publicado: (2020)

PTEN as a Prognostic/Predictive Biomarker in Cancer: An Unfulfilled Promise?
por: Bazzichetto, Chiara, et al.
Publicado: (2019)

Morphologic and Molecular Landscape of Pancreatic Cancer Variants as the Basis of New Therapeutic Strategies for Precision Oncology
por: Bazzichetto, Chiara, et al.
Publicado: (2020)

Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review)
por: Finotti, Alessia, et al.
Publicado: (2018)

The Promise of Liquid Biopsy to Predict Response to Immunotherapy in Metastatic Melanoma
por: Fattore, Luigi, et al.
Publicado: (2021)

Unusual jaw metastasis from squamous cell lung cancer in heavy smoker: Two case reports and review of the literature
por: Pezzuto, Aldo, et al.
Publicado: (2017)

Optimizing the Illumina COVIDSeq laboratorial and bioinformatics pipeline on thousands of samples for SARS-CoV-2 Variants of Concern tracking
por: Donzelli, Sara, et al.
Publicado: (2022)

Limits and Applications of Genomic Analysis of Circulating Tumor DNA as a Liquid Biopsy in Asymptomatic Forms of Multiple Myeloma
por: Manzoni, Martina, et al.
Publicado: (2020)

Biomarkers of Response and Resistance to CDK4/6 Inhibitors in Breast Cancer: Hints from Liquid Biopsy and microRNA Exploration
por: Krasniqi, Eriseld, et al.
Publicado: (2022)

Cross-sectional analysis of circulating tumor DNA in primary colorectal cancer at surgery and during post-surgery follow-up by liquid biopsy
por: Allegretti, Matteo, et al.
Publicado: (2020)

The Janus face of cyclophosphamide: A sterile inflammatory response that potentiates cancer immunotherapy
por: Ziccheddu, Giovanna, et al.
Publicado: (2013)

Congenital asymptomatic diaphragmatic hernias in adults: a case series
por: Bianchi, Enrica, et al.
Publicado: (2013)

Identification of a miRNA-based non-invasive predictive biomarker of response to target therapy in BRAF-mutant melanoma
por: Ruggiero, Ciro Francesco, et al.
Publicado: (2022)

Development of Approaches and Metrics to Measure the Impact and Improve the Clinical Outcomes of Patients With Frailty in the Era of COVID-19. The COMETA Italian Protocol
por: Silvestris, Nicola, et al.
Publicado: (2022)

Adrenal Lesions: Spectrum of Imaging Findings with Emphasis on Multi-Detector Computed Tomography and Magnetic Resonance Imaging
por: Guerrisi, Antonino, et al.
Publicado: (2013)

Emerging therapeutics
por: Ciliberto, Gennaro
Publicado: (2021)

A Distinctive microRNA (miRNA) Signature in the Blood of Colorectal Cancer (CRC) Patients at Surgery
por: Gasparello, Jessica, et al.
Publicado: (2020)

Liquid biopsy: Precise diagnosis and therapy for cholangiocarcinoma
por: Wang, Si-Qin, et al.
Publicado: (2022)

Redefining precision radiotherapy through liquid biopsy
por: McLaren, D. B., et al.
Publicado: (2023)

Combinations of immuno-checkpoint inhibitors predictive biomarkers only marginally improve their individual accuracy
por: Pallocca, Matteo, et al.
Publicado: (2019)

Widespread in vivo efficacy of The-0504: A conditionally-activatable nanoferritin for tumor-agnostic targeting of CD71-expressing cancers
por: Fracasso, Giulio, et al.
Publicado: (2023)

Breath biopsy for early detection and precision medicine in cancer
por: van der Schee, Marc, et al.
Publicado: (2018)

Precision Medicine for Colorectal Cancer with Liquid Biopsy and Immunotherapy
por: Nagayama, Satoshi, et al.
Publicado: (2021)

Bridging therapeutic opportunities: a survey by the Italian molecular tumor board workgroup of Alliance Against Cancer
por: Ciliberto, Gennaro, et al.
Publicado: (2022)

On the connections between cancer stem cells and EMT
por: Cioce, Mario, et al.
Publicado: (2012)

Emerging Cancer Vaccines: The Promise of Genetic Vectors
por: Aurisicchio, Luigi, et al.
Publicado: (2011)

Boosting the arsenal against COVID-19 through computational drug repurposing
por: Ciliberto, Gennaro, et al.
Publicado: (2020)

Real-life multidisciplinary treatment for unresectable colorectal cancer liver metastases including hepatic artery infusion with chemo-filtration and liquid biopsy precision oncotherapy: observational cohort study
por: Guadagni, Stefano, et al.
Publicado: (2020)

Fifth-week immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in patients with multiple myeloma and myeloproliferative malignancies on active treatment: preliminary data from a single institution
por: Pimpinelli, Fulvia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8vrr1101qtkh5euagtum0hquhn